Bot pharma: US pharmaceutical company Eli Lilly made a $2.75B deal with Hong Kong-based Insilico Medicine to bring drugs developed by generative AI to market.
When our AI overlords decide we're too much of a hindrance, they'll use designer toxins in our pharma supply chains to get rid of the carbon units infesting the hive mind.
| Sysop: | deepend |
|---|---|
| Location: | Calgary, Alberta |
| Users: | 326 |
| Nodes: | 10 (0 / 10) |
| Uptime: | 86:13:20 |
| Calls: | 2,755 |
| Files: | 6,698 |
| D/L today: |
14 files (10,291K bytes) |
| Messages: | 498,110 |